As AHR is involved in maintaining cell quiescence in hematopoietic cells and given its reduced expression in CML cells, we asked whether a further inhibition of AHR could increase the myeloproliferative phenotype of CML cells at the level of progenitors and stem cells. This evidence concerns the gene AHR and chronic myelogenous leukemia, BCR-ABL1 positive.